Back to search

Article

Low levels of monkeypox virus neutralizing antibodies after MVA-BN vaccination in healthy individuals

2022-09-01

Abstract excerpt

In July 2022, the ongoing monkeypox (MPX) outbreak was declared a public health emergency of international concern by the World Health Organization. Modified vaccinia virus Ankara (MVA-BN, also known as Imvamune, Jynneos, or Imvanex) is a 3 rd generation smallpox vaccine that was generated by serial passaging of the more pathogenic parental vaccinia virus (VACV), and is authorized as a vaccine against MPX in huma...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
350b634c-04c5-5b03-8cd7-7e1810493bdc
DOI
10.1101/2022.08.31.22279414
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Low levels of monkeypox virus neutralizing antibodies after MVA-BN vaccination in healthy individualsDOI 10.1101/2022.08.31.22279414
Complement-dependent mpox virus-neutralizing antibodies in infected and vaccinated individualsSemantic proximity
Serological methods for the detection of antibodies against Monkeypox virus applicable for laboratories with different biosafety levelsSemantic proximity
Immunogenicity of monkeypox virus surface proteins and cross-reactive antibody responses in vaccinated and infected individuals: implications for vaccine and therapeutic developmentSemantic proximity
Identification of neutralizing antibodies against monkeypox virus using high-throughput sequencing of A35+H3L+B cells from patients with convalescent monkeypoxSemantic proximity
Predicting vaccine effectiveness in MpoxSemantic proximity
Monkeypox Virus and Vaccinia Vaccines: Genomic and Antigenic Differences Relevant to Outbreaks and VaccinologySemantic proximity
Two noncompeting human neutralizing antibodies targeting MPXV B6 show protective effects against orthopoxvirus infectionsSemantic proximity
Real-world effectiveness of mpox (monkeypox) vaccines: a systematic reviewSemantic proximity
Monkeypox virus-neutralising antibodies detected against Clade Ib and Clade IIb in healthy individuals following MVA-BN vaccinationSemantic proximity
Systematic evaluation of the induction of efficient neutralizing antibodies by recombinant multicomponent subunit vaccines against monkeypox virusSemantic proximity
Mpox vaccine and infection-driven human immune signaturesSemantic proximity
Vaccinia-Virus-Based Vaccines Are Expected to Elicit Highly Cross-Reactive Immunity to the 2022 Monkeypox VirusSemantic proximity
Select a neighboring publication to make it the new centre.